Boston Scientific Indemnification asset increased by 2.9% to $212.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 15.8%, from $183.00M to $212.00M.
other_indemnification_asset| Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $163.00M | $168.00M | $172.00M | $170.00M | $168.00M | $165.00M | $176.00M | $175.00M | $172.00M | $183.00M | $188.00M | $187.00M | $206.00M | $212.00M |
| QoQ Change | — | — | +3.1% | +2.4% | -1.2% | -1.2% | -1.8% | +6.7% | -0.6% | -1.7% | +6.4% | +2.7% | -0.5% | +10.2% | +2.9% |
| YoY Change | — | — | — | — | — | +3.1% | -1.8% | +2.3% | +2.9% | +2.4% | +10.9% | +6.8% | +6.9% | +19.8% | +15.8% |